miércoles, 11 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· November 6, 2026

TEN Holdings Reports Third Quarter 2026 Financial Results

View original at finance.yahoo.com
“reducing short-term related-party borrowings from $4.6 million at the beginning of the year to approximately $0.1 million as of September 30, 2026”
Verbatim excerpt from the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Third quarter revenue increased 17.9% year over year to $640,000 from completed customer engagements initiated in prior periods plus new customers.

    60% confidence
  • Over the past 12 months the company reduced its annual operating cost structure by approximately $2.5 million through cost reductions, process improvements and AI-driven tools.

    60% confidence
  • Short-term related-party borrowings fell from $4.6 million at the start of the year to about $0.1 million at September 30, 2026; total liabilities fell ~74% from $7.7 million at year-end 2025 to $2.0 million.

    60% confidence
  • Q3 results include two non-recurring expenses: a $1.8 million write-off of previously capitalized service contracts and about $0.5 million in legal expenses; excluding them, underlying SG&A declined year over year.

    60% confidence
  • TEN represents an important step toward a scalable, SaaS-driven business model, unifying tools to create, manage, deliver and measure digital experiences.

    60% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,564 documentos fuente archivados
Consulta estos datos → isubstrate.com
TEN Holdings Reports Third Quarter 2026 Financial Results — Source | Via News | es.VIA.NEWS